153 related articles for article (PubMed ID: 28778478)
21. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
[TBL] [Abstract][Full Text] [Related]
22. Photoinduced RNA interference.
Matsushita-Ishiodori Y; Ohtsuki T
Acc Chem Res; 2012 Jul; 45(7):1039-47. PubMed ID: 22360585
[TBL] [Abstract][Full Text] [Related]
23. Peptide generated anisotropic gold nanoparticles as efficient siRNA vectors.
Panigrahi B; Mishra S; Singh RK; Siddiqui N; Bal R; Mandal D
Int J Pharm; 2019 May; 563():198-207. PubMed ID: 30953762
[TBL] [Abstract][Full Text] [Related]
24. A solution for highly efficient electroporation of primary cytotoxic T lymphocytes.
Alawar N; Schirra C; Hohmann M; Becherer U
BMC Biotechnol; 2024 Mar; 24(1):16. PubMed ID: 38532411
[TBL] [Abstract][Full Text] [Related]
25. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
[TBL] [Abstract][Full Text] [Related]
26. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
[TBL] [Abstract][Full Text] [Related]
27. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
28. Targeted Perturbation of Nuclear Envelope Integrity with Vapor Nanobubble-Mediated Photoporation.
Houthaeve G; Xiong R; Robijns J; Luyckx B; Beulque Y; Brans T; Campsteijn C; Samal SK; Stremersch S; De Smedt SC; Braeckmans K; De Vos WH
ACS Nano; 2018 Aug; 12(8):7791-7802. PubMed ID: 30001106
[TBL] [Abstract][Full Text] [Related]
29. A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.
Wang CW; Chung WH; Cheng YF; Ying NW; Peck K; Chen YT; Hung SI
J Allergy Clin Immunol; 2013 Sep; 132(3):713-722.e11. PubMed ID: 23791505
[TBL] [Abstract][Full Text] [Related]
30. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis.
Nemati H; Ghahramani MH; Faridi-Majidi R; Izadi B; Bahrami G; Madani SH; Tavoosidana G
J Control Release; 2017 Dec; 268():259-268. PubMed ID: 29074408
[TBL] [Abstract][Full Text] [Related]
31. Intracellular Delivery Platform for "Recalcitrant" Cells: When Polymeric Carrier Marries Photoporation.
Wu J; Xue H; Lyu Z; Li Z; Qu Y; Xu Y; Wang L; Yu Q; Chen H
ACS Appl Mater Interfaces; 2017 Jul; 9(26):21593-21598. PubMed ID: 28632379
[TBL] [Abstract][Full Text] [Related]
32. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.
Weber N; Ortega P; Clemente MI; Shcharbin D; Bryszewska M; de la Mata FJ; Gómez R; Muñoz-Fernández MA
J Control Release; 2008 Nov; 132(1):55-64. PubMed ID: 18727943
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
34. Photoporation-mediated spatial intracellular delivery of stem cell-derived cardiomyocytes.
Léger L; De Clercq C; Aalders J; Van Acker-Verberckt K; Braeckmans K; van Hengel J
MethodsX; 2024 Jun; 12():102548. PubMed ID: 38292311
[TBL] [Abstract][Full Text] [Related]
35. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation.
Prechtel AT; Turza NM; Theodoridis AA; Kummer M; Steinkasserer A
J Immunol Methods; 2006 Apr; 311(1-2):139-52. PubMed ID: 16556448
[TBL] [Abstract][Full Text] [Related]
36. RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis.
Javorovic M; Pohla H; Frankenberger B; Wölfel T; Schendel DJ
Mol Ther; 2005 Oct; 12(4):734-43. PubMed ID: 15921959
[TBL] [Abstract][Full Text] [Related]
37. Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
Ramishetti S; Kedmi R; Goldsmith M; Leonard F; Sprague AG; Godin B; Gozin M; Cullis PR; Dykxhoorn DM; Peer D
ACS Nano; 2015 Jul; 9(7):6706-16. PubMed ID: 26042619
[TBL] [Abstract][Full Text] [Related]
38. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
[TBL] [Abstract][Full Text] [Related]
39. Immobilization of HIV-1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery.
Ahwazi RP; Kiani M; Dinarvand M; Assali A; Tekie FSM; Dinarvand R; Atyabi F
J Cell Physiol; 2020 Mar; 235(3):2049-2059. PubMed ID: 31364167
[TBL] [Abstract][Full Text] [Related]
40. Phosphate-buffered saline-based nucleofection of primary endothelial cells.
Kang J; Ramu S; Lee S; Aguilar B; Ganesan SK; Yoo J; Kalra VK; Koh CJ; Hong YK
Anal Biochem; 2009 Mar; 386(2):251-5. PubMed ID: 19150324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
